华润三九医药股份有限公司 CR Sanjiu Medical & Pharmaceutical Co., Ltd.
China Resources Sanjiu Medical Co., Ltd., with a registered capital of 987.14 million yuan and a market valuation of 51.552 billion yuan, is a pillar enterprise for the people's livelihood in China. Its parent company, China Resources Co., Ltd. is a pillar enterprise of the people's livelihood that is 100% owned by the State Council, with a registered capital of 19,142.44 million yuan, ranking 66th in the "Top 500 World Brands" in 2022, and a total market value of 1.1 trillion Hong Kong dollars by the end of 2021.
China Resources (Group) Co., Ltd. is a central enterprise under the leadership of the State-owned Assets Supervision and Administration Commission of the State Council of China. It ranks 70th in the 2022 Global 500 list published by the 《Fortune》.
The stock code of China Resources 999 is 000999, and the current total market value is 7.2 billion dollars, stably maintaining the forefront of listed companies in the pharmaceutical industry.
Among the Top 100 Most Valuable Chinese Brands in Brand2019, China Resources 999 ranked 83rd due to its strong brand influence.
China Resources 999 has a rich product line, focusing on the field of medicine and health for 35 years, covering self-diagnosis and treatment, traditional Chinese medicine prescription drugs, formula granules, and anti-infection fields. The main core business is positioned in OTC and traditional Chinese medicine prescription drugs. In the future, China Resources 999 will continue to increase R&D investment in core products, prescription drugs, OTC and general health business, and the production platform will also focus on strengthening the development of medicinal material resources and improving the ability of intelligent manufacturing of traditional Chinese medicine.
Brand strength and honor；
International Laboratory Certification Organization Certification, diligently R&D High-tech Enterprise, China Accreditation Management System Certification, Top 100 Most Valuable Chinese Brands in 2019-WPP, Top 20 Competitive Pharmaceutical Listed Companies, Top 100 Most Valuable Chinese Main Board Listed Companies, and the Most Valuable Golden Bull investment.
Focusing on the field of medicine and health for 35 years: Guided by the mission of "caring for public health and creating a better life together", CR Sanjiu adheres to the values of "honesty and trustworthiness, performance orientation, people-oriented, innovative development", and strives to become a leader in the public medicine and health industry.